[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519043":3},{"organization":4,"armGroups":7,"interventions":26,"overallOfficials":32,"centralContacts":36,"locations":46,"responsibleParty":70,"collaborators":10,"id":72,"slug":73,"hasResults":74,"nctId":75,"briefTitle":76,"officialTitle":77,"acronym":10,"eligibilityCriteria":78,"healthyVolunteers":74,"sex":79,"minAge":80,"maxAge":10,"enrollmentInfo":81,"targetDuration":10,"studyType":84,"phases":10,"briefSummary":85,"conditions":86,"keywords":10,"overallStatus":49,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"RIVER Foundation","OTHER",[8,14,18,22],{"label":9,"type":10,"description":11,"interventionNames":12},"Chronic Pain",null,"The use of ketamine in chronic pain",[13],"Drug: Ketamine",{"label":15,"type":10,"description":16,"interventionNames":17},"Depressive Disorders","The use of ketamine in depressive disorders",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Anxiety Disorders","The use of ketamine in anxiety disorders",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Chronic Condtions","The use of ketamine in chronic conditions",[13],[27],{"type":28,"name":29,"description":30,"armGroupLabels":31,"otherNames":10},"DRUG","Ketamine","The efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the treatment plan of those with chronic conditions",[19,23,9,15],[33],{"name":34,"affiliation":5,"role":35},"Edward Lesofski, MS","STUDY_DIRECTOR",[37,42],{"name":38,"role":39,"phone":40,"phoneExt":10,"email":41},"Ed Lesofski","CONTACT","406-465-9504","ed@riverofchange.org",{"name":43,"role":39,"phone":44,"phoneExt":10,"email":45},"James Taggart, MD","415-713-6654","jrtaggartmd@aol.com",[47],{"facility":48,"status":49,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"RIVER Telehealth","RECRUITING","Helena","Montana","59601","United States","US",{"type":56,"coordinates":57},"Point",[58,59],-112.03611,46.59271,{"lat":59,"lon":58},[62,64,65,67,68],{"name":63,"role":39,"phone":40,"phoneExt":10,"email":41},"Ed Lesofski, MS",{"name":43,"role":39,"phone":10,"phoneExt":10,"email":10},{"name":66,"role":39,"phone":10,"phoneExt":10,"email":10},"Frank Yurasek, PhD",{"name":34,"role":39,"phone":10,"phoneExt":10,"email":10},{"name":69,"role":39,"phone":10,"phoneExt":10,"email":10},"Jeffery Newton",{"type":71,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100519043","ketamine-treatment-plans-for-chronic-conditions-100519043",false,"NCT06038409","Ketamine Treatment Plans for Chronic Conditions","Understanding the Safety of Home Ketamine Treatment Plans for Chronic Conditions","Inclusion Criteria:\n\nMust have an identifiable chronic condition.\n\nExclusion Criteria:\n\nHealthy population","ALL","18 Years",{"count":82,"type":83},500,"ESTIMATED","OBSERVATIONAL","A study aimed to assess the efficacy of the various approaches to prescribing Ketamine currently in use off-label. The focus will be to include ketamine within the study plan of those with chronic conditions who are receiving ketamine.",[9,87,19,88],"Depressive Disorder","Chronic Disease","2024-11-23",{"date":91,"type":92},"2024-11-26","ACTUAL",{"date":94,"type":92},"2023-01-01",{"date":96,"type":83},"2029-06-01",{"name":5,"class":6},1]